AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Compare cheap dividend ETFs to identify which has the best yield, balancing income with cost. Explore top contenders and make an informed choice.
27,900 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Pi Network's PI token fell about 4% this week, failing to hold above $0.13 as bears press the crucial support. The mo...
Tesla breaches a key price level near $382 as investors weigh margin pressures from tech compression and intensifying...
Cynthia Lummis gave clarity on timing for the CLARITY Act, but the Senate path remains uncertain as lawmakers juggle ...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
Crypto venture funds are widening bets beyond coins, aiming at fintech, AI, and infrastructure. The shift is designed...
A looming NBCUniversal spin-off reshapes the media landscape as Netflix weighs a transformative deal. If talks advanc...
Analysts warn that russia’s economy ‘sputtering,’ putin’s wartime spending model is under mounting pressure as sancti...
EasyJet reaches a takeover price with a U.S. investor, valuing the airline at about £2.6 billion, but traders doubt t...
Synopsys rides AI-driven demand in EDA and IP, delivering solid quarterly results and a robust backlog as the AI buil...
A niche crypto startup unveils a plan to tokenize a barrel of crude on a blockchain, potentially widening access to o...
Over the past seven years, Chinese electric-vehicle and battery makers have channeled more than $100 billion into ove...